These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6263473)

  • 1. Phase II evaluation of AMSA in adult sarcomas.
    Yap BS; Plager C; Benjamin RS; Murphy WK; Legha SS; Bodey GP
    Cancer Treat Rep; 1981; 65(3-4):341-3. PubMed ID: 6263473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of amsacrine (m-AMSA) in advanced lymphomas: a Southwest Oncology Group study.
    Weick JK; Jones SE; Ryan DH
    Cancer Treat Rep; 1983 May; 67(5):489-92. PubMed ID: 6687839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
    Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
    Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase I-II studies of a new antineoplastic agent, 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA)].
    Horikoshi N; Ogawa M; Inagaki J; Ezaki K; Inoue K; Okabe K; Nagata T; Aiba K; Domyo M
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):244-9. PubMed ID: 6897858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m-AMSA: phase II trial in advanced lymphoma and leukemia.
    Case DC
    Am J Clin Oncol; 1984 Aug; 7(4):357-60. PubMed ID: 6588746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study with amsacrines (m-AMSA and m-AMSA lactate) in refractory lymphomas.
    Bajetta E; Buzzoni R; Viviani S; Villani F; Piotti P; Gasparini G; Bonadonna G
    Cancer Treat Rep; 1985 Sep; 69(9):965-9. PubMed ID: 3839714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II evaluation of AMSA in patients with metastatic lung cancer.
    Nichols WC; Eagan RT; Frytak S; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1980; 64(12):1383-5. PubMed ID: 6894104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study.
    Ahmann FR; Meyskens FL; Jones SE; Bukowski RM; Saiers JH; Ryan DH; Costanzi J; Vaughn CB; Coltman CA
    Cancer Treat Rep; 1983; 67(7-8):697-700. PubMed ID: 6688199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of m-AMSA in patients with small-cell lung cancer.
    Natale RB; Gralla RJ; Wittes RE
    Cancer Clin Trials; 1981; 4(4):393-5. PubMed ID: 6274533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma.
    Sordillo PP; Magill GB; Gralla RJ; Golbey RB
    Cancer Treat Rep; 1980; 64(10-11):1129-30. PubMed ID: 6893950
    [No Abstract]   [Full Text] [Related]  

  • 11. A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer.
    Currie VE; Howard J; Wittes R
    Cancer Clin Trials; 1981; 4(3):249-51. PubMed ID: 6895189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m--anisidine (AMSA) in patients with advanced head and neck cancers.
    Ratanatharathorn V; Drelichman A; Sexon-Porte M; Al-Sarraf M
    Am J Clin Oncol; 1982 Feb; 5(1):29-32. PubMed ID: 6896258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.
    Woodcock TM; Schneider RJ; Young CW
    Cancer Treat Rep; 1980 Jan; 64(1):53-5. PubMed ID: 6892893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group Study.
    Bukowski RM; Legha S; Saiki J; Eyre HJ; O'Bryan R
    Cancer Treat Rep; 1982 Aug; 66(8):1651-2. PubMed ID: 6286120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancer.
    Tannir N; Spitzer G; Schell F; Legha S; Zander A; Blumenschein G
    Cancer Treat Rep; 1983 Jun; 67(6):599-600. PubMed ID: 6344995
    [No Abstract]   [Full Text] [Related]  

  • 16. Amsacrine in refractory acute leukemia.
    Griffin JD; Maguire ME; Mayer RJ
    Cancer Treat Rep; 1985; 69(7-8):787-9. PubMed ID: 3860296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I-II study of m-AMSA administered as a continuous infusion.
    Micetich KC; Zwelling LA; Gormley P; Young RC
    Cancer Treat Rep; 1982 Oct; 66(10):1813-7. PubMed ID: 6897013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of advanced colorectal carcinoma with AMSA.
    Ferraro JA; Horton J; Weissman C; Ruckdeschel JC; O'Donnell M; Ludlum D
    Cancer Treat Rep; 1981; 65(3-4):345-7. PubMed ID: 6894563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer.
    Valdivieso M; Stroehlein JR; Bedikian AY; Karlin DA; Legha SS; Bennetts RW; Bodey GP
    Am J Clin Oncol; 1983 Feb; 6(1):39-44. PubMed ID: 6687657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II. Trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in the treatment of advanced non-Hodgkin's lymphoma.
    Warrell RP; Straus DJ; Young CW
    Cancer Treat Rep; 1980; 64(10-11):1157-8. PubMed ID: 6893952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.